文献速递心律失常心力衰竭与心肌病

心血管磁共振心肌纤维化对非缺血性心肌病心律失常风险的分层

Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy.
PubMed 文献 · J Am Coll Cardiol · 2024-08-30

在推导队列866例和验证队列848例非缺血性心肌病患者中,量化总心肌纤维化和灰区纤维化,发现视觉评估心肌纤维化可预测室性心律失常或心源性猝死,总纤维化质量增加风险递增,而左室射血分数<35%预测价值差。

要点

  • 视觉评估心肌纤维化是非缺血性心肌病患者室性心律失常和心源性猝死的强预测因子。
  • 总心肌纤维化>10g者风险最高,0-10g为中等风险,无纤维化风险最低。
  • 左室射血分数<35%对心律失常风险区分能力差。

核心结论

  • 视觉评估心肌纤维化是非缺血性心肌病患者心源性猝死和室性心律失常的强预测因子。
  • 总心肌纤维化和灰区纤维化质量在视觉评估基础上提供增量价值。
  • 左室射血分数对心律失常风险区分能力差。

研究设计与样本

  • 推导队列866例非缺血性心肌病患者,验证队列848例,均接受心血管磁共振量化总心肌纤维化和灰区纤维化。
  • 主要复合终点为心源性猝死或室性心律失常(室颤或室速)。

主要发现

  • 推导队列中52/866(6.0%)达到主要终点,中位随访7.5年(Q1-Q3: 5.2-9.3年)。
  • 竞争风险分析中,视觉评估心肌纤维化预测主要终点HR 5.83(95%CI 3.15-10.8)。
  • 总纤维化>0g且≤10g风险中等(HR 4.03;95%CI 1.99-8.16),>10g风险最高(HR 9.17;95%CI 4.64-18.1),以无视觉评估心肌纤维化为参照。
  • 验证队列中左室射血分数<35%预测主要终点HR 1.99(95%CI 0.99-4.01)。

关键数值与推荐

  • 总纤维化>0g且≤10g为中等风险组,>10g为最高风险组,无视觉评估心肌纤维化为最低风险组。
  • 总纤维化或灰区纤维化单独或联合均可实现上述三组风险分类。

临床怎么用

  • 在非缺血性心肌病患者的风险分层中,应考虑使用心血管磁共振量化心肌纤维化(总纤维化和灰区纤维化)以补充视觉评估。
  • 左室射血分数<35%不应作为唯一的心律失常风险分层依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myocardial fibrosis (MF) forms part of the arrhythmic substrate for ventricular arrhythmias (VAs). OBJECTIVES: This study sought to determine whether total myocardial fibrosis (TF) and gray zone fibrosis (GZF), assessed using cardiovascular magnetic resonance, are better than left ventricular ejection fraction (LVEF) in predicting ventricular arrhythmias in patients with nonischemic cardiomyopathy (NICM). METHODS: Patients with NICM in a derivation cohort (n = 866) and a validation cohort (n = 848) underwent quantification of TF and GZF. The primary composite endpoint was sudden cardiac death or VAs (ventricular fibrillation or ventricular tachycardia). RESULTS: The primary endpoint was met by 52 of 866 (6.0%) patients in the derivation cohort (median follow-up: 7.5 years; Q1-Q3: 5.2-9.3 years). In competing-risks analyses, MF on visual assessment (MFVA) predicted the primary endpoint (HR: 5.83; 95% CI: 3.15-10.8). Quantified MF measures permitted categorization into 3 risk groups: a TF of >0 g and ≤10 g was associated with an intermediate risk (HR: 4.03; 95% CI: 1.99-8.16), and a TF of >10 g was associated with the highest risk (HR: 9.17; 95% CI: 4.64-18.1) compared to patients with no MFVA (lowest risk). Similar trends were observed in the validation cohort. Categorization into these 3 risk groups was achievable using TF or GZF in combination or in isolation. In contrast, LVEF of <35% was a poor predictor of the primary endpoint (validation cohort HR: 1.99; 95% CI: 0.99-4.01). CONCLUSIONS: MFVA is a strong predictor of sudden cardiac death and VAs in NICM. TF and GZF mass added incremental value to MFVA. In contrast, LVEF was a poor discriminator of arrhythmic risk.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Hammersley DJ, Zegard A, Androulakis E, et al. Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy. J Am Coll Cardiol. 2024. PMID: 39217566. doi:10.1016/j.jacc.2024.06.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。